Nuclear Medicine- Table of Contents

Apr 2, 2002

Nuclear Medicine- Table of Contents

Scott C. Williams, MD

Contributors

General Nuclear Medicine

Cardiac Imaging

Central Nervous System

Endocrine: Thyroid & Parathyroid

Genitourinary

Gastrointestinal

Infection and Inflammation

Musculoskeletal: Bone/Soft Tissues and Lymphatics

Positron Emission Tomography (PET)

Pulmonary

Tumor Imaging and Radionuclide Therapy

Radioscintigraphic Assay and Volumetry (RIA)

Radiation Biology

(C) 1995-2024 Scott Williams, M.D.

Digital illustration of a glowing human heart with technological and medical monitoring elements integrated into a blue digital interface background.

Jubilant to invest 94.5M CAD in manufacturing facility

October 9, 2026

Nuclidium images first patient in phase II trial of Cu-61 PSMA tracer

October 6, 2026

Explore Innovations at EANM 2026

Explore Innovations at EANM 2026

October 1, 2026

Scientist in lab coat holding glowing atomic symbol representing scientific innovation and research

Radnostix to sell nuclear fuel processing assets for $13.5M

October 1, 2026

Jubilant to invest 94.5M CAD in manufacturing facility

By AuntMinnie.com staff writers

The investment will double output of the firm's RubyFill rubidium-82 chloride cardiac PET agent.

October 9, 2026

Digital illustration of a glowing human heart with technological and medical monitoring elements integrated into a blue digital interface background.

Nuclidium images first patient in phase II trial of Cu-61 PSMA tracer

By AuntMinnieEurope.com staff writers

The trial will enroll nearly three dozen patients with biopsy-confirmed metastatic prostate cancer at U.S. sites.

October 6, 2026

GE HealthCare to acquire Sofie Biosciences for $945M

By AuntMinnie.com staff writers

The deal is expected to close in the first half of 2027.

October 5, 2026

Scattered US dollar bills including $100 and $1 denominations arranged in overlapping pattern

Radnostix to sell nuclear fuel processing assets for $13.5M

By AuntMinnie.com staff writers

Assets include a U.S. Nuclear Regulatory Commission (NRC) license, patented technology, and related technical materials.

October 1, 2026

Scientist in lab coat holding glowing atomic symbol representing scientific innovation and research

Eden selects Kiewit as partner for NM isotope facility

By AuntMinnie.com staff writers

The project is expected to create 205 jobs and generate more than $1.5 billion in economic impact over 10 years.

September 28, 2026

Telix inks deal to acquire ITM for $1.65B

By Erik L. Ridley

The deal would create a combined company with significant radioisotope manufacturing, distribution, and radiopharmaceutical development capabilities.

September 21, 2026

Glowing atomic nucleus symbol with orbiting electrons in a modern laboratory setting with industrial equipment

Curium gets FDA approval for Lu-177 injection for GEP-NETs

By AuntMinnie.com staff writers

The radioligand therapy delivers targeted radiation to GEP-NETs by binding to somatostatin receptors expressed on these tumors.

September 15, 2026

Blue approved stamp seal with distressed circular border and diagonal banner

Ionetix begins shipping At-211 in North America

By AuntMinnie.com staff writers

Alpha emitters like At-211 deliver high-energy radiation over a very short range.

September 2, 2026

Hand holding glowing atom symbol with orbital rings on blue technology background

IU Health launches theranostics center

By AuntMinnie.com staff writers

The center is supported by a $40 million commitment.

August 19, 2026

Hand presenting glowing atom model with orbital rings in blue and gold light against blurred background

Radnostix reports revenue decline in Q2

By AuntMinnie.com staff writers

The company attributed the revenue dip to two voluntary product recalls and the Cobalt-60 hot-cell shutdown.

August 13, 2026

Overlapping U.S. dollar bills showing Benjamin Franklin portrait and Federal Reserve seal

ITM receives Complete Response Letter for ITM-11

By AuntMinnie.com staff writers

The FDA stated that it's unable to approve the NDA in its present form.

August 10, 2026

Hand holding glowing atomic nucleus symbol with orbiting electrons against blue technology background

Plus Therapeutics rebrands as Cerenome

By AuntMinnie.com staff writers

The move reflects the company's evolution from a therapeutics-focused organization into an integrated central nervous system (CNS) oncology company.

August 3, 2026

Plus Therapeutics and Ceremone company logos featuring geometric symbols and branded text

Page 1 of 445